Cargando…
Prevention of Bone Growth Defects, Increased Bone Resorption and Marrow Adiposity with Folinic Acid in Rats Receiving Long-Term Methotrexate
The underlying pathophysiology for bone growth defects in paediatric cancer patients receiving high dose methotrexate chemotherapy remains unclear and currently there are no standardized preventative treatments for patients and survivors. Using a model in young rats, we investigated damaging effects...
Autores principales: | Fan, Chia-Ming, Foster, Bruce K., Hui, Susanta K., Xian, Cory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465278/ https://www.ncbi.nlm.nih.gov/pubmed/23071661 http://dx.doi.org/10.1371/journal.pone.0046915 |
Ejemplares similares
-
Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity
por: Peymanfar, Yaser, et al.
Publicado: (2022) -
Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.
por: Bernard, S., et al.
Publicado: (1991) -
miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2
por: Zhang, Ya-Li, et al.
Publicado: (2021) -
Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow
Publicado: (1987) -
Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain
por: OGUSHI, Naofumi, et al.
Publicado: (2018)